Writing
Insights
Articles on biotech web design, science communication, and what it actually takes to make a life sciences company look credible to the people who matter.
The Pre-Seed Biotech Website: Minimum Viable Credibility for Your First Raise
You do not have Phase I data or a twenty-person team. Here is what the site actually has to do to look legitimate to the people writing your first check.
Why Biotech Websites Need Scientific Native Translation
The hidden cost of generalist agencies for biotech: wasted hours explaining basic science and errors in the final site. The case for a science-native builder.
Visualizing Mechanism of Action for Series A Investors
Why generalist agencies ruin MoA graphics, and how accurate mechanism-of-action visualization signals scientific rigor to Series A biotech investors.
Digital Architecture for Molecular Diagnostics Websites
How to translate complex assay data for the web: interactive HRM melt curves, multiplex PCR visualization, and proving technical superiority to partners.
Exiting Stealth Mode Without Leaking Your Biotech IP
How to launch your biotech digital presence to attract talent and funding while protecting proprietary technology. Balancing technical depth with IP.
Designing a Clinical Pipeline Page for Due Diligence
The anatomy of a biotech clinical pipeline page that survives institutional due diligence: phase clarity, linked data, and science-accurate milestone copy.